Clinovo Joins Forces with Ennov to Add a Safety Solution to its E-Clinical Suite

Share Article

FDA compliant Pharmacovigilance Solution PV247 Now Available in Clinovo’s Comprehensive eClinical Suite through Strategic Partnership with Ennov.

Clinovo

Clinovo

Clinovo, provider of e-clinical systems with the only free validated electronic data capture (EDC) software (ClinCapture), joins forces with Ennov, a leading provider of Pharmacovigilance software solutions. With the addition of this 21 CFR part 11 compliant Pharmacovigilance solution, Clinovo further extends its eClinical suite and positions itself as a leading eClinical systems provider in the clinical trial space.

“We are thrilled to have Ennov as a technology partner,” says Ale Gicqueau, President of Clinovo. “Ennov is a well-known leader in providing secure and validated Pharmacovigilance software solutions for the Life Sciences industry. With this Pharmacovigilance module, we are strengthening our offering to small and mid-size companies, looking for sophisticated solutions at an affordable cost.”

Over the half decade, Clinovo has built a comprehensive eClinical suite, composed of clinical trial solutions that integrate and complement its flagship product ClinCapture EDC. Clinovo’s eClinical suite includes EDC, ePRO (Patient Reported Outcome), CTMS (Clinical Trial Management System), Safety solution, CDISC Express (CDISC conversion system), and many more. ClinCapture’s eClinical Suite extends Clinovo’s EDC capabilities and meets the needs of medical device and pharmaceutical companies looking for integrated solutions to run efficient clinical trials.

Ennov makes cost effective, comprehensive, and user-friendly solutions for regulated content management. With offices in Europe and the U.S, it serves 150+ Life Science customers, ranging from leading pharmaceutical companies to emerging biotechnology companies throughout the Life Science industry.

“We share with Clinovo the same vision,” says Olivier Paris, President of Ennov. “Providing sophisticated and compliant solutions while remaining affordable. At Ennov, we’re committed to relentlessly innovating our products to meet the most demanding business challenges."

Ennov provides two easy-to-use turnkey software solutions for human and veterinary pharmacovigilance. Ennov’s flagship product PV247 comes with an intuitive interface that integrates to each company’s workflow.

Link to Ennov webinar

Clinovo’s flagship product ClinCapture features a self-service platform and do-it-yourself CRF and edit-check builder allowing clinical trials managers to create CRFs and edit checks in a matter of days, without any programming experience. ClinCapture is the only electronic data capture solution (EDC) system hosted in a 21 CFR Part 11 compliant cloud hosting environment, available without charge for its Standard package.

Link to ClinCapture Virtual Update (CVU) webinar

About Ennov:
Ennov designs, develops and distributes EDM and workflow software for the life sciences industry. The Ennov solution encompasses 4 main areas: clinical trials, regulatory affairs, pharmacovigilance and quality. Ennov solutions are used around the world by thousands of individual users at hundreds of sites including Air Liquid, Merial, Novartis, Stallergènes, Virbac or Famar. Ennov is certified ISO 9001:2008.
For further details see http://www.ennov.com.

About Clinovo:
Clinovo is a leading provider of cloud-based eClinical software. Clinovo’s flagship solution ClinCapture® is the only validated electronic data capture software, available for free. ClinCapture empowers CROs, Pharmaceuticals and Medical Device companies to build studies themselves, lower their clinical trials costs and streamline their data capture processes. Clinovo is headquartered in the Silicon Valley.

Contact Information:
Sophie McCallum | Director of Operations
sophie(dot)mccallum(at)clinovo(dot)com | +1 (408) 773 6258

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sophie McCallum
Clinovo
+1 408-773-6258
Email >
@Clinovo
Follow >
Follow us on
Visit website